This rare condition involves an overgrowth of cells in your body's lymph nodes. Treatment varies depending on how many lymph nodes are involved.
Update Date: 18.09.2026
By Mayo Clinic Staff
Castleman disease is a group of rare conditions that cause enlarged lymph nodes and a wide range of symptoms. The most common type affects a single lymph node, usually in the chest or neck. But it can occur in other areas. This form of the disease is called unicentric Castleman disease (UCD).
Multicentric Castleman disease (MCD) involves multiple regions of enlarged lymph nodes. It can cause inflammatory symptoms and issues with organ function. There are three types of MCD:
Sometimes, people may have 2 to 3 enlarged lymph nodes and mild symptoms that do not meet the standards used to diagnose for MCD. These people may have another disease, or they may have the recently described subtype of Castleman disease called oligocentric. This also is known as regional Castleman disease. This subtype is rare.
Treatment and outlook vary depending on the type of Castleman disease you have. Unicentric Castleman disease, which involves only one enlarged lymph node, can usually be successfully treated with surgery.
The best treatment for oligocentric Castleman disease, which involves a few enlarged lymph nodes and has limited symptoms, is not known. But it is thought to be similar to the treatment for unicentric Castleman disease.
Not all people with MCD respond to the first treatment. But medicines are available that can help treat HHV-8-associated MCD and idiopathic MCD.
Many people with unicentric Castleman disease don't notice any signs or symptoms. The enlarged lymph node may be found during a physical exam or an imaging test for a different issue.
Some people with unicentric Castleman disease might have signs and symptoms that are more often seen in multicentric Castleman disease. These may include:
These symptoms may include:
Lab test results may include:
Symptoms of the more serious form of idiopathic MCD called iMCD-TAFRO are:
If you notice an enlarged lymph node on the side of your neck or in your underarm, collarbone or groin area, talk with your healthcare professional. Also call your care team if you have a lasting sense of fullness in your chest or abdomen, fever, fatigue, or weight loss that you can't explain.
It's not clear what causes unicentric Castleman disease or idiopathic multicentric Castleman disease (MCD). But HHV-8-positive MCD is known to occur in people whose immune systems are weakened, including people with HIV.
Castleman disease can affect people of any age. People usually are diagnosed with Castleman disease during midlife, but it can happen at any age, including during childhood.
There are no known risk factors for unicentric Castleman disease or idiopathic multicentric Castleman disease. Infection with HIV or having a condition that decreases how well the immune system works raises the risk of having HHV-8-positive multicentric Castleman disease.
People with unicentric Castleman disease (UCD) usually do well once the affected lymph node is removed, and life expectancy is usually not changed. But people with this condition are at increased risk of developing a rare autoimmune condition called paraneoplastic pemphigus. This condition can be life-threatening. Paraneoplastic pemphigus causes blisters in the mouth and on the skin that are often misdiagnosed. Though the risk of developing paraneoplastic pemphigus is low, being checked for this condition is important if you have UCD.
Idiopathic multicentric Castleman disease can rapidly get worse and involve life-threatening issues with organ function. This requires critical care with a machine that helps with breathing, called a ventilator, and treatments that help with organ function, such as dialysis and transfusions.
HHV-8-positive multicentric Castleman disease may involve life-threatening infections and organ failure. People who also have HIV/AIDS can have worse outcomes.
After reviewing your medical history and doing a detailed physical exam, your healthcare professional may recommend:
Treatment depends on the type of Castleman disease you have.
Surgery to remove the affected lymph node is the usual treatment for unicentric Castleman disease (UCD). If the lymph node is in the chest or abdomen, major surgery may be needed.
Surgery to remove the enlarged lymph node usually cures UCD. But the condition sometimes comes back. If surgery is not possible, you may need medicines typically used for multicentric Castleman disease. If medicines don't work, radiation therapy may be an option.
You'll likely need follow-up exams, including imaging and laboratory tests, to check that the disease hasn't come back.
Treatment of oligocentric Castleman disease, a rare subtype, is usually similar to that of UCD. But more research is needed.
Rituximab (Rituxan, Ribani, others) is usually the first treatment for HHV-8-positive MCD. Rituximab is highly effective, but sometimes medicines called antivirals and chemotherapies are needed. Antiviral medicines can block the activity of HHV-8 or HIV, and chemotherapies can get rid of extra immune cells.
Siltuximab (Sylvant) is usually the first treatment for idiopathic MCD. In the U.S., siltuximab is the only medicine approved by the Food and Drug Administration (FDA) for the treatment of idiopathic MCD. People who get better after taking siltuximab tend to have successful long-term treatment. This drug blocks the action of a protein called interleukin-6. The bodies of people who have idiopathic MCD produce too much of this protein.
People who are critically ill with idiopathic MCD often receive treatment with medicines called corticosteroids. They also may need chemotherapy. Corticosteroids such as prednisone can help control inflammation. Chemotherapy can get rid of immune cells that are causing issues.
When siltuximab doesn't work, other treatments such as rituximab (Rituxan, Ribani, others) and sirolimus (Rapamune) may be used.
You may be referred to a doctor trained in treating blood conditions. This type of doctor is called a hematologist.
In addition to the questions that you've prepared to ask your healthcare professional, don't hesitate to ask other questions during your appointment.
Your healthcare team is likely to ask you a number of questions. Being ready to answer these questions may leave time to go over points you want to spend more time on. You may be asked:
© 2026 Mayo Foundation for Medical Education and Research. All rights reserved. Terms of Use